KEGG   DRUG: Ardenermin
Entry
D02979                      Drug                                   

Name
Ardenermin (USAN);
BLyS (TN)
Sequence
AVQGPEETVT QDCLQLIADS ETPTIQKGSY TFVPWLLSFK RGSALEEKEN KILVKETGYF
FIYGQVLYTD KTYAMGHLIQ RKKVHVFGDE LSLVTLFRCI QNMPETLPNN SCYSAGIAKL
EEGDELQLAI PRENAQISLD GDVTFFGALK LL
  Type
Peptide
Efficacy
Antineoplastic
Comment
B cell survival factor that affects B cell representation and serum immunoglobulins in patients with congenital or acquired immunodeficiencis (tumor necrosis factor)
Target
TNFSF13B (BAFF, CD257) [HSA:10673] [KO:K05476]
  Pathway
hsa04064  NF-kappa B signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Tumor necrosis factors
    TNFSF13B (BAFF, CD257)
     D02979  Ardenermin (USAN)
Other DBs
CAS: 305391-49-5
PubChem: 17397135

» Japanese version   » Back

DBGET integrated database retrieval system